Document is current
Any future updates will be listed below
-
Authors
Rammant, Elke
Deman, Emile
Fonteyne, Valérie
Poppe, Lindsay
Bultijnck, Renée
Dirix, Piet
De Meerleer, Gert
Haustermans, Karin
Van Hecke, Ann
Aguado-Barrera, Miguel E.
Avuzzi, Barbara
Azria, David
Chang-Claude, Jenny
Chiorda, Barbara N.
Choudhury, Ananya
Calvo-Crespo, Patricia
De Ruysscher, Dirk
Gómez-Caamaño, Antonio
Heumann, Philipp
Hopkins, Ashley M.
Johnson, Kerstie
Lambrecht, Maarten
Mcwilliam, Alan
Menz, Bradley D.
Poelaert, Filip
Rancati, Tiziana
Rans, Kato
Rattay, Tim
Rosenstein, Barry S.
Seibold, Petra
Shortall, Jane
Sperk, Elena
Sundahl, Nora
Talbot, Christopher J.
Vega, Ana
Vermeulen, Peter
Webb, Adam
West, Catharine M. L.
Veldeman, Liv
Van Hoecke, Sofie
,
-
Funding
Funding for this research was provided by:
Kom op tegen Kanker
the European Union’s Seventh Framework Programme for research, technological development, and demonstration (no. 601826)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 25 November 2025
First Online: 29 November 2025
Declarations
:
: The study was carried out in compliance with the Helsinki Declaration. The REQUITE study was approved by the local Ethical Committees of each participating country (UK NRES Approval 14/NW/0035). Prior to participation, all individuals were thoroughly informed about the study’s objectives and methods. Written consent was obtained from the participants before the commencement of data collection.
: Not applicable.
: Nora Sundahl reports speakers fees from Janssens-CILAG.The salary of Ashley M. Hopkins is supported by a National Health and Medical Research Council (NHMRC) of Australia Investigator Grant. Ashley M. Hopkins reports receiving funding from Tour De Cure and The Hospital Research Foundation outside of the study. Ashley M. Hopkins reports grant funding from Boehringer Ingelheim outside of the submitted work.
